ZENTALIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98943L907. A total of 3 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,270 | -75.9% | 4,500 | -66.2% | 0.00% | -100.0% |
| Q2 2023 | $375,193 | -21.4% | 13,300 | -43.9% | 0.00% | 0.0% |
| Q4 2022 | $477,318 | +2707.8% | 23,700 | +3850.0% | 0.00% | – |
| Q2 2022 | $17,000 | -96.2% | 600 | -93.9% | 0.00% | – |
| Q1 2022 | $452,000 | +1.3% | 9,800 | +84.9% | 0.00% | – |
| Q4 2021 | $446,000 | +565.7% | 5,300 | +430.0% | 0.00% | – |
| Q3 2021 | $67,000 | -75.3% | 1,000 | -80.4% | 0.00% | – |
| Q2 2021 | $271,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 4,700 | $80 | 0.00% |
| JANE STREET GROUP, LLC | 16,400 | $282,080 | 0.00% |